Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure

Type 2 diabetes (T2D) is associated with β-cell dedifferentiation. Aldehyde dehydrogenase 1 isoform A3 (ALHD1A3) is a marker of β-cell dedifferentiation and correlates with T2D progression. However, it is unknown whether ALDH1A3 activity contributes to β-cell failure, and whether the decrease of ALD...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature communications Jg. 14; H. 1; S. 558 - 14
Hauptverfasser:	Son, Jinsook, Du, Wen, Esposito, Mark, Shariati, Kaavian, Ding, Hongxu, Kang, Yibin, Accili, Domenico
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London Nature Publishing Group UK 02.02.2023 Nature Publishing Group Nature Portfolio
Schlagworte:	13/106 13/31 13/51 14/19 38 38/91 42 45 631/136/142 631/136/2435 631/443/319/1642/137/773 631/80/304 64 64/60 Ablation Aldehyde dehydrogenase Aldehyde Dehydrogenase 1 Family Aldehyde Oxidoreductases - metabolism Aldehydes Animals Beta cells Blood glucose Cell differentiation Cell Line, Tumor Diabetes Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Experimental - drug therapy Diabetes Mellitus, Experimental - genetics Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - genetics Humanities and Social Sciences Insulin Insulin secretion Insulin-Secreting Cells - metabolism Mice multidisciplinary Pharmacology Science Science (multidisciplinary) Tracing
ISSN:	2041-1723, 2041-1723
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!